The global ophthalmology devices market is expected to
grow at a CAGR of 3.74% during the forecast period. Some of the prominent
vendors in the market include Alcon Inc., Bausch Health Companies Inc., Carl Zeiss
AG, EssilorLuxottica SA, HOYA Corp., Johnson & Johnson Services Inc., NIDEK
Co. Ltd., The Cooper Co. Inc., and among others.
For More Information: Request Free Sample Pages
Strategic collaborations and M&A are an ongoing trend in the global
ophthalmology devices market. In March 2019, Alcon announced the acquisition of
PowerVision Inc., a US-based medical device development company that focused on
creating fluid-based IOL implants. In February 2019, Essilor International (Essilor),
which is the subsidiary of EssilorLuxottica SA, announced that it had acquired
a majority stake in InduLentes, one of the leading prescription laboratories in
Ecuador.
In October 2018, Carl Zeiss Meditec announced it had entered into an
agreement to acquire IanTECH, the developer of the miLOOP device, a
micro-interventional device designed to deliver energy-free endocapsular lens
fragmentation. In October 2018, HOYA Surgical Optics, the
intraocular lens and related products division of HOYA Corp. (HOYA), announced
that it had entered into a definitive agreement to acquire two medical device
companies, the US-based Medical Instrument Development Laboratories Inc. Such
strategic collaborations and M&A in the global
ophthalmology devices market help the vendors to expand their product
portfolios.
No comments:
Post a Comment